Antibody persistence 22 months after vaccination of adolescents with the Novartis investigational meningococcal ACWY-CRM197 conjugate vaccine or Menactra®
Author(s) -
Christopher Gill,
A. Anemoma,
Giuseppe Ciavarro,
A. Kleinschmidt,
Peter Dull
Publication year - 2010
Publication title -
international journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.278
H-Index - 89
eISSN - 1878-3511
pISSN - 1201-9712
DOI - 10.1016/j.ijid.2010.02.611
Subject(s) - medicine , vaccination , meningococcal vaccine , immunogenicity , conjugate vaccine , titer , persistence (discontinuity) , neisseria meningitidis , meningococcal disease , immunology , antibody , antibody titer , immunization , biology , geotechnical engineering , engineering , genetics , bacteria
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom